Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOFLAVIN 5^-PHOSPHATE Cause No adverse event? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of No adverse event have been filed in association with RIBOFLAVIN 5^-PHOSPHATE. This represents 15.6% of all adverse event reports for RIBOFLAVIN 5^-PHOSPHATE.

38
Reports of No adverse event with RIBOFLAVIN 5^-PHOSPHATE
15.6%
of all RIBOFLAVIN 5^-PHOSPHATE reports
0
Deaths
0
Hospitalizations

How Dangerous Is No adverse event From RIBOFLAVIN 5^-PHOSPHATE?

Of the 38 reports.

Is No adverse event Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN 5^-PHOSPHATE. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOFLAVIN 5^-PHOSPHATE Cause?

Eye pain (53) Visual impairment (44) Corneal opacity (40) Therapy cessation (30) Drug ineffective (26) Corneal infiltrates (25) Corneal scar (22) Device issue (20) Incorrect product administration duration (17) Product use issue (16)

What Other Drugs Cause No adverse event?

OMALIZUMAB (9,736) ALBUTEROL (8,971) ETONOGESTREL (8,827) TOCILIZUMAB (6,492) RITUXIMAB (5,915) METHYLPHENIDATE (4,197) MOMETASONE FUROATE (3,717) HUMAN IMMUNOGLOBULIN G (3,064) ETHINYL ESTRADIOL\NORELGESTROMIN (3,014) VEDOLIZUMAB (2,477)

Which RIBOFLAVIN 5^-PHOSPHATE Alternatives Have Lower No adverse event Risk?

RIBOFLAVIN 5^-PHOSPHATE vs RIFABUTIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPICIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMPIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAMYCIN RIBOFLAVIN 5^-PHOSPHATE vs RIFAPENTINE

Related Pages

RIBOFLAVIN 5^-PHOSPHATE Full Profile All No adverse event Reports All Drugs Causing No adverse event RIBOFLAVIN 5^-PHOSPHATE Demographics